Part D marketing fails to meet CMS guidelines 85% of time
Executive SummaryHHS' Office of Inspector General says that most marketing material for Medicare Part D prescription drug plans fails to meet at least one element of CMS guidelines, ranging from details about PDP benefits and rules to requirements for footnote font size. "It's unconscionable that CMS has let the insurance industry's materials - including essential items like pharmacy directories and summaries of benefits - fail to properly inform seniors 85 percent of the time," Senate Finance Committee Chairman Max Baucus, D-Mont., said. "CMS says it's making changes to correct these problems, and you'd better believe the Finance Committee will move to make sure seniors get better service one way or the other.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.